+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID01731444

Study Comparing Phenylephrine and Epinephrine Solutions to Reduce Blood Loss During Burn Surgery

Led by University of Manitoba · Updated on 2026-05-14

24

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of phenylephrine compared to epinephrine to control blood loss during skin graft surgery for burn injuries covering 5-30% of total body surface area. This Phase 1 randomized trial aims to find out if phenylephrine can reduce blood loss without affecting heart rate or blood pressure, as epinephrine sometimes causes increases in these vital signs. Participants will receive injections under the skin of the burn injury site with either a phenylephrine solution or the standard epinephrine solution before skin grafting. The procedure and grafting technique remain the same only the solution used for tumescence differs. The study compares these two drugs to assess their effects during surgery. During the first 30 minutes after injection, researchers will monitor mean arterial blood pressure closely, along with blood pressure and heart rate every 15 minutes. The study involves careful observation of these vital signs to evaluate the safety and effectiveness of phenylephrine in controlling blood loss. The total participation duration and further follow-up details are not specified.

CONDITIONS

Brief Title

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Research Team

J

Justin Gawaziuk, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here